These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up. Björkholm M; Celsing F; Johansson E; Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163 [No Abstract] [Full Text] [Related]
25. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966 [TBL] [Abstract][Full Text] [Related]
26. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068 [TBL] [Abstract][Full Text] [Related]
27. Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Diviné M; Casassus P; Koscielny S; Bosq J; Sebban C; Le Maignan C; Stamattoulas A; Dupriez B; Raphaël M; Pico JL; Ribrag V; ; Ann Oncol; 2005 Dec; 16(12):1928-35. PubMed ID: 16284057 [TBL] [Abstract][Full Text] [Related]
28. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma. Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445 [TBL] [Abstract][Full Text] [Related]
29. The 2000 Burkitt lymphoma trial in Malawi. Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922 [TBL] [Abstract][Full Text] [Related]
30. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948 [TBL] [Abstract][Full Text] [Related]
31. Results of treatment of 112 cases of primary CNS lymphoma. Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337 [TBL] [Abstract][Full Text] [Related]
32. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia. Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604 [TBL] [Abstract][Full Text] [Related]
33. Acute renal failure in African children with Burkitt's lymphoma: a comparison of two treatment regimens. Olowu WA; Elusiyan JB; Badejo SA; Adenowo OA Pediatr Blood Cancer; 2006 Apr; 46(4):446-53. PubMed ID: 16206217 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150 [TBL] [Abstract][Full Text] [Related]
35. Long-term results of dose density therapy in patients with aggressive lymphoma. Fridrik MA; Hausmaninger H; Linkesch W; Greil R; Krieger O; Baldinger C; Klocker J; Pont J; Oberaigner W Ann Hematol; 2005 Apr; 84(4):217-22. PubMed ID: 15538568 [TBL] [Abstract][Full Text] [Related]
36. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cortes J; Thomas D; Rios A; Koller C; O'Brien S; Jeha S; Faderl S; Kantarjian H Cancer; 2002 Mar; 94(5):1492-9. PubMed ID: 11920506 [TBL] [Abstract][Full Text] [Related]
37. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Agha-Razii M; Amyot SL; Pichette V; Cardinal J; Ouimet D; Leblanc M Clin Nephrol; 2000 Jul; 54(1):59-63. PubMed ID: 10939758 [TBL] [Abstract][Full Text] [Related]
38. High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients. van 't Veer MB; de Jong D; MacKenzie M; Kluin-Nelemans HC; van Oers MH; Zijlstra J; Hagenbeek A; van Putten WL Br J Haematol; 2009 Feb; 144(4):524-30. PubMed ID: 19036081 [TBL] [Abstract][Full Text] [Related]
39. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Galicier L; Fieschi C; Borie R; Meignin V; Daniel MT; Gérard L; Oksenhendler E Blood; 2007 Oct; 110(8):2846-54. PubMed ID: 17609431 [TBL] [Abstract][Full Text] [Related]